B. Riley reaffirmed their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday morning, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. HROW has been the subject of several other reports. Lake Street […]
Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 2,210,000 shares, a growth of 6.8% from the March 31st total of 2,070,000 shares. Based on an average daily volume of 376,400 shares, the days-to-cover ratio is […]
Acuitas Investments LLC lowered its position in Harrow Health, Inc. (NASDAQ:HROW – Get Rating) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 238,241 shares of the company’s stock after selling 99,708 shares during the period. Harrow Health […]
Harrow Health, Inc. (NASDAQ:HROW – Get Rating) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $25.76 and last traded at $25.37, with a volume of 218258 shares trading hands. The stock had previously closed at $24.15. Analyst Upgrades and Downgrades A number of equities analysts have […]
Should You Buy or Sell Harrow Health Stock? Get The Latest HROW Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.